Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
about
Tight Junctions Go Viral!New hepatitis C virus drug discovery strategies and model systemsTree shrew (Tupaia belangeri) as a novel laboratory disease animal modelInterferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysisDetermination of the human antibody response to the neutralization epitopes encompassing amino acids 313-327 and 432-443 of hepatitis C virus E1E2 glycoproteinsAn interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses.Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human HepatocytesIdentification and Characterization of Liver MicroRNAs of the Chinese Tree Shrew via Deep Sequencing.Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.CD36 is a co-receptor for hepatitis C virus E1 protein attachment.Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews.Detection and analysis of tupaia hepatocytes via mAbs against tupaia serum albumin.An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.CXCL10 decreases GP73 expression in hepatoma cells at the early stage of hepatitis C virus (HCV) infection.CD81 and hepatitis C virus (HCV) infection.How hepatitis C virus invades hepatocytes: the mystery of viral entryComplete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.Animal models for the study of hepatitis C virus infection and replication.Hepatitis C virus infection and related liver disease: the quest for the best animal modelFunctional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a trans-Complementation System Reveals a Dual Role of a Putative Fusion Peptide of E1 in both HCV Entry and Morphogenesis.Exosomal MicroRNAs Derived From Umbilical Mesenchymal Stem Cells Inhibit Hepatitis C Virus Infection.Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model.Tree shrew, a potential animal model for hepatitis C, supports the infection and replication of HCV in vitro and in vivo.Insilico modeling and molecular dynamic simulation of claudin-1 point mutations in HCV infection.Interaction of L-SIGN with hepatitis C virus envelope protein E2 up-regulates Raf-MEK-ERK pathway.Genome of the Chinese tree shrew.Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function
P2860
Q26781335-C69FBF6A-5B28-44DA-861F-2AA613547151Q26851159-086AEDF0-460F-4F27-ABC1-E5439E0065DDQ33766929-FD8B69FC-2162-4ABB-A027-785466181D31Q34653087-457C4CB4-B577-41C1-BD17-C2C439B1D038Q34796179-40435434-79D4-4C11-BD19-2C36B10715BCQ35162433-8270A7D1-48EB-44A1-A99E-42BC60CED07EQ35270150-A4D1A2F9-853E-4ABF-978B-66165CF12F65Q36037497-98101393-0549-4758-AD33-12CAA678C6EBQ36279237-8444D1F0-AD43-4FB4-8ADC-2D48A98C2ADDQ36318779-92472B9D-F658-4F17-9BD8-9EA54375509DQ36602246-E71ABC7B-5999-4EE7-893E-D0D66FF00904Q36666366-87DD264A-068E-42E7-B5D7-37322CF6F0D5Q36918300-6631A502-FEEB-4F9B-B745-0D3ECD99D592Q37252982-6084DCE3-707A-4400-B583-52E08B2EDA6AQ37420981-E60BC8DA-F72E-400B-8CAA-0DAC63BA699FQ37611819-63D4AE87-36C6-4402-83FD-28D5F7E02E05Q37682499-877B9B32-9AD6-4E0B-A1FB-4734D87180EEQ38010203-126B0092-867E-47B3-A78E-94644F057894Q38021989-66456BEF-C2BB-471F-A9F5-BC2FCFECF618Q38125192-6E581098-8520-4803-A472-5E3E1D9968CEQ38720669-3C4CE0A7-24C8-4D82-BC24-70E13E3C2D50Q38833929-61FD1C99-0D2C-4F1F-998A-347BFD4DECB3Q39532092-E0ED67AB-EBA2-4C34-8C8B-F9ED41A779A9Q40081918-FFFA4075-D2ED-43EB-BCA3-262F1BB6E442Q40101596-5D518AB1-822E-42F7-9C94-3CCCD2B2286BQ42279087-EE2A44BC-DE6F-4A5D-8B5C-325F96C8826CQ42827093-6E3791E7-7722-49EF-AA26-4997E4EAFAA4Q42988951-4A4A4440-E22B-4168-8296-25D60DA3CF4BQ57115959-FBE45078-3A60-47A5-AB44-479F008B5632
P2860
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@ast
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@en
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@nl
type
label
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@ast
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@en
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@nl
prefLabel
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@ast
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@en
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@nl
P2093
P2860
P356
P1433
P1476
Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
@en
P2093
Mark A Feitelson
Xueshan Xia
Yimin Tong
Yongzhe Zhu
Yongzhi Wang
P2860
P304
P356
10.1128/JVI.01818-10
P407
P577
2010-12-22T00:00:00Z